Archive for December, 2007
Brokeback Pharma
Please note: As some of you may have noticed, we’ve been having some problems getting our blog up on its regular site (http://bpblog.avelient.com) over the last week. This is partially due to some upgrades that are being applied to our blogging software and a new look we’re planning for release soon. As a [...]
Rx Email
So before you ask, no, I did not write this on Christmas day. I do have limits. I wrote this on Friday December 21st, actually — but through the miracle of technology I was able to set up my blog software to post it for me on my usual Tuesday schedule. Having done that, [...]
Alpha-Genics
Our blog today comes from David Crider, currently a graduate student in the Cell Biology/Pathology program at Columbia University. He is also a consultant for Biocatalyst and the Development manager for Alpha-Genics. Alpha-Genics is the first company to provide personalized products based on your own unique genetic profile. Along with his recent work as a [...]
The Pipeline Floodeth
My latest issue of the Pharmaceutical Executive recently came in the mail, its cover heralding its report on the 2007 pipeline for drug companies. The story covers 61 offerings that are being developed at the big pharmaceutical companies to treat a variety of diseases. I examined it with great interest, taking particular note [...]
Bad Week for Pfizer
As you may already know, I used to be a consultant for Pfizer. I worked on a project where I was surrounded by great people, had a fantastic rapport with the business owners, and overall felt good about the work I was doing there. The feeling was buoyed by the company’s great balance [...]
Loading ...